Advertisement

Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x100px
Organisation › Details

European Pharma Oligonucleotide Consortium (EPOC)

The European Pharma Oligonucleotide Consortium (EPOC) was founded by seven pharmaceutical companies that came together to assemble and make freely available knowledge that will promote harmonisation of strategies for oligonucleotide development. The founding companies proactively engaged with each other to form the consortium and since the beginning of 2018 have worked to develop an operating framework and have progressed the first topics of interest, evaluating and interpreting our individual experience in preparation for publication. The consortium operates pre-competitively, not aiming to develop intellectual property, harnessing the information each company can share with the aim of publishing common findings and strategies to enable all of the oligonucleotide community, regardless of their direct involvement in EPOC, to benefit from enhanced understanding and harmonised approaches. *

 

Period Start 2018-01-01 established
Product Industry  oligo synthesis
     
Region Region Europe
  City n. a. 
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: European Pharma Oligonucleotide Consortium (EPOC). (1/25/19). Web Site: European Pharma Oligonucleotide Consortium [incl. EPOC Presenation by Roche Orr, 8 November 2018, at EuroTides]. [www.epoconsortium.com, 01/25/19]
     
   
Record changed: 2023-07-10

Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for European Pharma Oligonucleotide Consortium (EPOC)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x300px




» top